Mobile Menu

Search Results

Search results for: Real World Study

LEGEND: Large-scale Evidence Generation and Evaluation across a Network of Databases

The Observational Health Data Sciences and Informatics (OHDSI) international collaborative have launched a research initiative known as LEGEND. The aim […]

MethylationToActivity: A deep-learning framework that infers promoter activity

A recent study, published as a preprint in bioRxiv, presents a new machine learning framework – MethylationToActivity. This framework uses […]

Validating a new text mining tool for electronic health records

Researchers have undertaken a validation study, using patients with metastatic renal cell carcinoma (mRCC), to assess the efficiency of a […]

COVID-19 clinical trials failing to enrol diverse populations

Despite global recognition that diversity within population studies is poor, clinical trials for current treatments and vaccines for COVID-19 still […]

Where are AstraZeneca investing in digital health?

Three Digital Health R&D leaders at AstraZeneca outlined in a recent post how the organisation is harnessing data, analytics and […]

Promises and pitfalls of precision medicine clinical trials, now and in the future

Availiable on demand here As we move towards an ever more personalised healthcare system, genomics is at the heart of […]

10 MIT-IBM Watson AI Lab funded COVID-19 projects

Artificial intelligence, unsurprisingly, has been the leading technology pitched to solve most of our newfound pandemic problems, from finding a […]

AI & RWD April publications – Covid-19 round-up

A new month means a new round-up of the more pertinent publications, kindly collated by Benjamin Hughes, SVP at IQVIA. […]

Pharma-published AI & RWD articles

Benjamin Hughes, Senior Vice President of AI and RWD at IQVIA, has collated the sixteen most interesting publications from this […]

Interview with Dr Rona Strawbridge, UKRI Innovation

Dr Rona Strawbridge has been using genetics to try to understand complex diseases, who’s work has focused much on obesity, type 2 diabetes and cardiovascular disease, and more recently serious mental illness. We managed to have a chat with Rona ahead of her speaking at the Festival of Genomics about her work and why she’s excited to be speaking at the festival this year.